Results 131 to 140 of about 25,666 (269)

Nutrition and Reproduction in Transition Cows [PDF]

open access: yes, 2019
This information was presented at the 2019 Herd Health and Nutrition Conference.The transition from late pregnancy to the onset of lactation is the most challenging period in the life of a dairy cow – metabolically, health-wise, and nutritionally.
Butler, Ron
core  

A review of capillary β‐hydroxybutyrate cut‐off levels for the exclusion and identification of diabetic ketoacidosis

open access: yesJournal of Diabetes Investigation, EarlyView.
Potential application of capillary β‐OHB in triaging patients by emergency services. ABSTRACT Aims/Introduction Diabetic ketoacidosis (DKA) is an acute, life‐threatening emergency that can arise as a complication of diabetes mellitus. We sought to examine the literature regarding capillary β‐OHB testing levels that can inform cut‐offs and help ...
Nghiep Tran   +8 more
wiley   +1 more source

Effects of Prepartum Supplementation and Yeast Fermentation Products on the Progesterone‐Modulated Transfer of Passive Immunity in Bos indicus Cows

open access: yesJournal of Animal Physiology and Animal Nutrition, EarlyView.
ABSTRACT Inadequate colostrum intake increases risks of calf morbidity and mortality. This study investigated the effects of prepartum and early postpartum supplementation and yeast fermentation products on late‐pregnant Bos indicus cows, and the role of progesterone in mediating passive immunity transfer.
Latino G. S. Coimbra   +3 more
wiley   +1 more source

Bacterial Methane Oxidation and its Influence in the Aquatic Environment [PDF]

open access: yes, 1974
This study was supported in part by the Office of Water Resources Research, U.S. Department of the Interior under Project A-027-OHIO.(print) vii, 133 p. : ill. ; 29 cm.Table of Contents -- List of Tables -- List of Figures -- 1. Introduction -- 2. Review
Dugan, Patrick R., Weaver, Terry L.
core  

Narcolepsy and rapid eye movement sleep

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Since the first description of narcolepsy at the end of the 19th Century, great progress has been made. The disease is nowadays distinguished as narcolepsy type 1 and type 2. In the 1960s, the discovery of rapid eye movement sleep at sleep onset led to improved understanding of core sleep‐related disease symptoms of the disease (excessive ...
Francesco Biscarini   +4 more
wiley   +1 more source

Iron Regulates Cellular Proliferation by Enhancing the Expression of Glucose Transporter GLUT3 in the Liver

open access: yesCells
Iron is often accumulated in the liver during pathological conditions such as cirrhosis and cancer. Elevated expression of glucose transporters GLUT1 and GLUT3 is associated with reduced overall survival in patients with hepatocellular carcinoma. However,
Kleber S. Ribeiro   +9 more
doaj   +1 more source

Sleep Improvement for Metabolic Health: A Feasibility Trial of a Digital Sleep Treatment in People With Insomnia and Non‐Diabetic Hyperglycaemia

open access: yesJournal of Sleep Research, EarlyView.
ABSTRACT Insomnia may play a causal role in type 2 diabetes (T2D). Addressing insomnia through cognitive behavioural therapy (CBTi) in people with non‐diabetic hyperglycaemia could potentially reduce the risk of progression to T2D. To inform a future randomised trial, we performed a feasibility study of digital CBT (dCBTi) in individuals at increased ...
Rachel Sharman   +11 more
wiley   +1 more source

Aminolysis of poly (.BETA.-hydroxybutyrate) and its copolymer.

open access: yesSen'i Gakkaishi, 1992
Poly (β-hydroxybutyrate) and its copolymer poly (β-hydroxybutyrate-co-β-hydroxyvalerate) P (HB-co-HV) were treated with methyl- and ethylamines. Melting peak temperatures, number-average molecular weights (Mn) and long spacings (L) of treated samples decreased as the concentration of amines or the treating time increased.
openaire   +2 more sources

Effects of Oral Single‐Dose Empagliflozin on Urinary Glucose, Serum β‐Hydroxybutyrate, and Plasma Empagliflozin Concentrations in Healthy Adult Dogs

open access: yesJournal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT Empagliflozin is a sodium‐glucose cotransporter‐2 inhibitor used for treating humans with heart failure, among other conditions. This drug could have applications in veterinary cardiology, but whether empagliflozin has biological effects in dogs when administered at dosages approximating human therapeutic dosages is unknown.
Andrea D. Plá Gutierrez   +5 more
wiley   +1 more source

Controlled biotechnological production of polyhydroxyalkanoates [PDF]

open access: yes, 2012
Předložená diplomová práce se zabývá produkcí polyhydroxyalkanoátů (PHA) bakterií Cupriavidus necator H16. Cílem práce byla příprava, selekce a charakterizace mutantních kmenů schopných vyšší produkce PHA.
Šnajdar, Ondřej
core  

Home - About - Disclaimer - Privacy